Archived Newsletters

  1. 12.05.22 -- Listen now: Oligonucleotide Therapy Delivery, Product vs. Platform, and more. 12/5/2022
    12/05/22 Outsourced Pharma Newsletter
  2. 12.05.22 -- 4 Core Values For Outsourcing 12/5/2022
    12/05/22 Outsourced Pharma Newsletter
  3. 12.05.22 -- In-Vivo CAR T Update 12/5/2022
    12/05/22 Outsourced Pharma Newsletter
  4. 12.05.22 -- Frequent Deficiencies In GMP Inspections 12/5/2022
    12/05/22 Outsourced Pharma Newsletter
  5. 12.05.22 -- Frequent Deficiencies In GMP Inspections 12/5/2022
    12/05/22 Outsourced Pharma Newsletter
  6. 12.01.22 -- Streamline The Development Of Plasmid And Viral Vectors 12/1/2022

    12/01/22 Outsourced Pharma Newsletter

  7. 12.01.22 -- The Advantages Of Unit/Bi-Dose Nasal Delivery Technology 12/1/2022

    12/01/22 Outsourced Pharma Newsletter

  8. 11.30.22 -- Key Components For Early Phase Trials 11/30/2022

    11/30/22 Outsourced Pharma Newsletter

  9. 11.30.22 -- CDMO Performance 11/30/2022
    11/30/22 Outsourced Pharma Newsletter
  10. 11.29.22 -- Enhancing Bioavailability: A Science-Based Technology Selection Process 11/29/2022

    11/29/22 Outsourced Pharma Newsletter